Lymphadenopathy epidemiology and demographics

Lymphadenopathy Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Lymphadenopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT scan
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Lymphadenopathy epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Lymphadenopathy epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Lymphadenopathy epidemiology and demographics
CDC on Lymphadenopathy epidemiology and demographics
Lymphadenopathy epidemiology and demographics in the news
Blogs on Lymphadenopathy epidemiology and demographics
Directions to Hospitals Treating Lymphadenopathy
Risk calculators and risk factors for Lymphadenopathy epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Epidemiology and Demogaphics

The estimated incidence of lymphadenopathy in children in the United States ranges from 35% - 45%.

It is more common in the pediatric population.

Race and gender have no predilection in lymphadenopathy incidence.